Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsOperating LeasesOther Accumulated ExpensesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lexaria Bioscience (LEXX) Other Accumulated Expenses (2025)

Historic Other Accumulated Expenses for Lexaria Bioscience (LEXX) over the last 4 years, with Q4 2025 value amounting to $1.5 million.

  • Lexaria Bioscience's Other Accumulated Expenses changed N/A to $1.5 million in Q4 2025 from the same period last year, while for Nov 2025 it was $1.5 million, marking a year-over-year change of. This contributed to the annual value of $1.1 million for FY2011, which is 275.67% up from last year.
  • Lexaria Bioscience's Other Accumulated Expenses amounted to $1.5 million in Q4 2025.
  • Lexaria Bioscience's Other Accumulated Expenses' 5-year high stood at $1.5 million during Q4 2025, with a 5-year trough of $1.5 million in Q4 2025.